I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Kutyna, Monika
22
results:
Search for persons
X
Format
Online (22)
Mediatypes
Articles (Online) (13)
OpenAccess-fulltext (9)
Sorted by: Relevance
Sorted by: Year
?
1
Clonal Architecture of Donor-Derived Myeloid Neoplasms afte..:
Wechalekar, Gauri
;
Cibich, Ms. Alia
;
Shanmuganathan, Naranie
...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S350-S351 , 2024
Link:
https://doi.org/10.1016/..
?
2
IDH-mutant myeloid neoplasms are associated with seronegati..:
Hong, Lih En
;
Wechalekar, Mihir D.
;
Kutyna, Monika
...
Blood. 143 (2024) 18 - p. 1873-1877 , 2024
Link:
https://doi.org/10.1182/..
?
3
TP53mutation in therapy-related myeloid neoplasm defines a ..:
Hiwase, Devendra
;
Hahn, Christopher
;
Tran, Elizabeth Ngoc Hoa
...
Blood. 141 (2023) 9 - p. 1087-1091 , 2023
Link:
https://doi.org/10.1182/..
?
4
A Personalized Risk Model for Azacitidine Outcome in Myelod..:
Sharplin, Kirsty
;
Proudman, William
;
Chhetri, Rakchha
...
Cancers. 15 (2023) 16 - p. 4019 , 2023
Link:
https://doi.org/10.3390/..
?
5
Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is ..:
Thomas, Daniel
;
Wu, Manhong
;
Nakauchi, Yusuke
...
Cancer Discovery. 13 (2022) 2 - p. 496-515 , 2022
Link:
https://doi.org/10.1158/..
?
6
3170 – ABERRANT BONE MARROW MICROENVIRONMENT IN THERAPY REL..:
Kutyna, Monika
;
Paton, Sharon
;
Gronthos, Stan
.
Experimental Hematology. 76 (2019) - p. e3-e4 , 2019
Link:
https://doi.org/10.1016/..
?
7
Inclusion of RBC-Transfusion Dependency Improves the Progno..:
Hiwase, Devendra K.
;
Singhal, Deepak
;
Chhetri, Rakchha
...
Clinical Lymphoma Myeloma and Leukemia. 15 (2015) - p. S44 , 2015
Link:
https://doi.org/10.1016/..
?
8
Case report: Rare case of donor cell‐derived T‐cell acute l..:
Eadie, Laura N.
;
Rehn, Jacqueline A.
;
Schutz, Caitlin E.
...
British Journal of Haematology. 203 (2023) 2 - p. 282-287 , 2023
Link:
https://doi.org/10.1111/..
?
9
Solute Carrier Family 29A1 Mediates In Vitro Resistance to ..:
Kutyna, Monika M.
;
Loone, Sophie
;
Saunders, Verity A.
...
International Journal of Molecular Sciences. 24 (2023) 4 - p. 3553 , 2023
Link:
https://doi.org/10.3390/..
?
10
A senescence stress secretome is a hallmark of therapy-rela..:
Kutyna, Monika M.
;
Kok, Chung Hoow
;
Lim, Yoon
...
Leukemia. 36 (2022) 11 - p. 2678-2689 , 2022
Link:
https://doi.org/10.1038/..
?
11
Targeted gene panels identify a high frequency of pathogeni..:
Singhal, Deepak
;
Hahn, Christopher N.
;
Feurstein, Simone
...
Leukemia. 35 (2021) 11 - p. 3245-3256 , 2021
Link:
https://doi.org/10.1038/..
?
12
The mutational burden of therapy-related myeloid neoplasms ..:
Singhal, Deepak
;
Wee, Li Yan A.
;
Kutyna, Monika M.
...
Leukemia. 33 (2019) 12 - p. 2842-2853 , 2019
Link:
https://doi.org/10.1038/..
?
13
Dynamic assessment of RBC‐transfusion dependency improves t..:
Hiwase, Devendra K.
;
Singhal, Deepak
;
Strupp, Corinna
...
American Journal of Hematology. 92 (2017) 6 - p. 508-514 , 2017
Link:
https://doi.org/10.1002/..
?
14
Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is ..:
Thomas, Daniel
;
Wu, Manhong
;
Nakauchi, Yusuke
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900324/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
15
Solute Carrier Family 29A1 Mediates In Vitro Resistance to ..:
Kutyna, Monika M
;
Loone, Sophie
;
Saunders, Verity A
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965596/. , 2023
Link:
http://www.ncbi.nlm.nih...
1-15
